Related Suggestion
(Feb 9, 2023, Dubai, UAE) From February 6
to 9, 2023, Fapon Biotech Inc. (Fapon Biotech or the Company) attended the Medlab
Middle East (Medlab ME) in Dubai, UAE. At the exhibition, Fapon Biotech
presented its upgraded product portfolio, including core IVD raw materials,
reagent services and open instrument platforms. Above all, the Company
introduced and drew attention to its one-stop solutions in both the chemiluminescence
and rapid test industry.
With the aim of paving the way for
technological advancements and sustainability in laboratory medicine, the 22nd edition of the Medlab ME annual gathering brought together 700+ exhibitors from
40+ countries, showcasing the latest laboratory innovations and technologies. With
over two decades of R&D experience and extensive resources from across the
globe, Fapon Biotech is now a leading and pivotal company in both the Chinese life
sciences industry and the global IVD industry. The Company met with worldwide
IVD partners at Medlab ME, showcasing its advancements and latest IVD innovations.
Open
Instrument Platforms on Display
Two of Fapon Biotech’s
featured instruments were on full display, namely Shine i1000 chemiluminescence
immunoassay analyzer and Shine i2000 chemiluminescence
immunoassay analyzer. Equipped with Fapon Biotech’s excellent core raw
materials and reagent services, the instruments is capable of providing a one-stop
solution for chemiluminescence immunoassay. In addition, Fapon Biotech has
brought about two new instruments specially designed for molecular diagnostics.
One was the FAtraction32 Nucleic Acid Extraction System, which uses magnetic
bead separation technology to transfer magnetic beads between deep-well plates
containing specific reagents. The other was the FAlight16 Rapid Real-time
fluorescent quantitative PCR system, which uses innovative liquid circulation
refrigeration combined with unique Peltier temperature control technology to
ensure uniform and precise temperature control that is equivalent to the performance
of a desktop qPCR analyzer.
Expansive
Chemiluminescence Ecosystem Empowers Partners
In accordance with the mission of empowering
timely, accurate and affordable diagnosis for all, Fapon Biotech has launched
its expansive ecosystem concept for chemiluminescence immunoassay, which
empowers partners to transform them from dealers to manufacturers. Fapon
Biotech introduced its self-developed series of high-performance
chemiluminescence immunoassay analyzers that are open and fully customizable: Shine
i1000, the smallest fully automatic chemiluminescence immunoassay analyzer which
has three different models of AE, AP and HRP protocols, and Shine i2000, the compact
yet robust and large capacity analyzer which has four different models of AE,
AP, HRP, ABEI protocols.
With over two decades of experience in the
IVD industry, Fapon Biotech has established a comprehensive technology platform
and developed a wide range of product lines. It now provides compact, accurate
and affordable chemiluminescence analyzers via Fapon’s ecosystem reagent
panels. Additionally, technical services such as factory construction design,
product registration support, construction of quality assurance system,
professional and quick customer services are also available.
Powerful Technical Transfer
Empowers Local Rapid Test Industry
After the COVID-19 epidemic, the government
has gradually realized the importance of the local development of IVD companies,
and many countries have introduced policies to encourage localized production,
such as Indonesia, Kenya, Egypt, etc. Considering the huge pressure surrounding
cost and fierce market competition for localized production, Fapon Biotech has
launched a one-stop rapid test solution to help worldwide local enterprises
build their own brands from 0 to 1. From plant construction to equipment
purchase, from personnel training to production supply, Fapon Biotech has been providing
comprehensive and tailored localized production solutions. Leaning on its
thorough understanding of raw materials, the Company has continuously empowered
overseas markets and gradually helped partners localize production. Take its
Indian market as an example, Fapon Biotech’s underlying technology has
empowered many top medical device customers in building diagnostic product
lines in India.
Focused on IVD underlying technology and product R&D, Fapon Biotech will continue to harness its global innovation network and contribute to the global IVD industry’s progression and development with more partners.